Goodchild C S, Noble J
Br J Clin Pharmacol. 1987 Mar;23(3):279-85. doi: 10.1111/j.1365-2125.1987.tb03046.x.
Nine patients were given intrathecal injections of midazolam (dose 0.3-2 mg dissolved in 3 ml 5% dextrose). No changes in motor power or general sensation were produced. Resting heart rate and blood pressure were unchanged and normal valsalva manoeuvres were elicited 30 min post-injection. Cardiovascular responses were provoked at a light plane of anaesthesia by intubation of the trachea and manipulation of peritoneum and bowel but not by surgical incision of the skin. Intrathecal administration of midazolam relieved post-operative pain of somatic origin but not of visceral origin. It is concluded that intrathecal midazolam in the dosage used interrupts somatic nociceptive afferent pathways but not abdominal visceral nociceptive afferent pathways.
9名患者接受了鞘内注射咪达唑仑(剂量为0.3 - 2毫克,溶于3毫升5%葡萄糖溶液中)。未出现运动能力或一般感觉的变化。静息心率和血压未改变,注射后30分钟能引出正常的瓦尔萨尔瓦动作。在浅麻醉平面下,气管插管、腹膜和肠道操作可引发心血管反应,但皮肤手术切口不会引发。鞘内注射咪达唑仑可缓解躯体源性术后疼痛,但不能缓解内脏源性术后疼痛。得出的结论是,所用剂量的鞘内咪达唑仑可阻断躯体伤害性传入通路,但不能阻断腹部内脏伤害性传入通路。